Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPT plus thalidomide and dexamethasone vs placebo plus thalidomide and dexamethasone in relapsed or refractory multiple myeloma
CTR20140751Phase 3Completed
- Sponsor
- Shadong Biotech
- Start
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of circularly permuted TRAIL in multiple myeloma (MM), sponsored by Shadong Biotech. Started Jan 2015; status: completed.
02
Drugs
circularly permuted TRAIL
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on CTR20140751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140751.